Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol

Ji Yeon Park, Young Woo Kim, Keun Won Ryu, Byung Ho Nam, Young Joon Lee, Sang Ho Jeong, Ji Ho Park, Hoon Hur, Sang Uk Han, Jae Seok Min, Ji Yeong An, WooJin Hyung, Gyu Seok Cho, Gui Ae Jeong, Oh Jeong, Young Kyu Park, Mi Ran Jung, Hong Man Yoon, Bang Wool Eom

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: Along with the marked increase in early gastric cancer (EGC) in the Eastern countries, there has been an effort to adopt the sentinel node concept in EGC to preserve gastric function and reduce the occurrence of postoperative complications. Based on promising results from a previous quality control study, this prospective multicenter randomized controlled phase III clinical trial aims to elucidate the oncologic safety of laparoscopic stomach-preserving surgery with sentinel basin dissection (SBD) compared to a standard laparoscopic gastrectomy. Methods/Design: This trial is an investigator-initiated, open-label, multicenter randomized controlled phase III trial with a non-inferiority design. Patients diagnosed with a single lesion of clinical stage T1N0M0 gastric adenocarcinoma, with a diameter of 3 cm or less are eligible for the present study. A total of 580 patients (290 per group) will be randomized to either laparoscopic stomach-preserving surgery with SBD or standard surgery. The primary end-point is 3-year disease-free survival (DFS) and the secondary endpoints include postoperative morbidity and mortality, quality of life, 5-year DFS, and overall survival. Qualified investigators who completed the prior quality control study are exclusively allowed to participate in this phase III clinical trial. Discussion: The proposed trial is expected to verify whether laparoscopic stomach-preserving surgery with SBD achieves similar oncologic outcomes and improved quality of life compared to a standard gastrectomy in EGC patients. Trial registration: This study was registered at the NIH ClinicalTrial.gov database ( NCT01804998 ) on March 4th, 2013.

Original languageEnglish
Article number340
JournalBMC cancer
Volume16
Issue number1
DOIs
Publication statusPublished - 2016 May 31

Fingerprint

Phase III Clinical Trials
Gastrectomy
Clinical Protocols
Lymph Node Excision
Stomach Neoplasms
Dissection
Stomach
Randomized Controlled Trials
Quality Control
Disease-Free Survival
Quality of Life
Research Personnel
Controlled Clinical Trials
Multicenter Studies
Adenocarcinoma
cyhalothrin
Databases
Prospective Studies
Morbidity
Safety

All Science Journal Classification (ASJC) codes

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Park, Ji Yeon ; Kim, Young Woo ; Ryu, Keun Won ; Nam, Byung Ho ; Lee, Young Joon ; Jeong, Sang Ho ; Park, Ji Ho ; Hur, Hoon ; Han, Sang Uk ; Min, Jae Seok ; An, Ji Yeong ; Hyung, WooJin ; Cho, Gyu Seok ; Jeong, Gui Ae ; Jeong, Oh ; Park, Young Kyu ; Jung, Mi Ran ; Yoon, Hong Man ; Eom, Bang Wool. / Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol. In: BMC cancer. 2016 ; Vol. 16, No. 1.
@article{57378617143c4a4299413771bbc15f28,
title = "Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol",
abstract = "Background: Along with the marked increase in early gastric cancer (EGC) in the Eastern countries, there has been an effort to adopt the sentinel node concept in EGC to preserve gastric function and reduce the occurrence of postoperative complications. Based on promising results from a previous quality control study, this prospective multicenter randomized controlled phase III clinical trial aims to elucidate the oncologic safety of laparoscopic stomach-preserving surgery with sentinel basin dissection (SBD) compared to a standard laparoscopic gastrectomy. Methods/Design: This trial is an investigator-initiated, open-label, multicenter randomized controlled phase III trial with a non-inferiority design. Patients diagnosed with a single lesion of clinical stage T1N0M0 gastric adenocarcinoma, with a diameter of 3 cm or less are eligible for the present study. A total of 580 patients (290 per group) will be randomized to either laparoscopic stomach-preserving surgery with SBD or standard surgery. The primary end-point is 3-year disease-free survival (DFS) and the secondary endpoints include postoperative morbidity and mortality, quality of life, 5-year DFS, and overall survival. Qualified investigators who completed the prior quality control study are exclusively allowed to participate in this phase III clinical trial. Discussion: The proposed trial is expected to verify whether laparoscopic stomach-preserving surgery with SBD achieves similar oncologic outcomes and improved quality of life compared to a standard gastrectomy in EGC patients. Trial registration: This study was registered at the NIH ClinicalTrial.gov database ( NCT01804998 ) on March 4th, 2013.",
author = "Park, {Ji Yeon} and Kim, {Young Woo} and Ryu, {Keun Won} and Nam, {Byung Ho} and Lee, {Young Joon} and Jeong, {Sang Ho} and Park, {Ji Ho} and Hoon Hur and Han, {Sang Uk} and Min, {Jae Seok} and An, {Ji Yeong} and WooJin Hyung and Cho, {Gyu Seok} and Jeong, {Gui Ae} and Oh Jeong and Park, {Young Kyu} and Jung, {Mi Ran} and Yoon, {Hong Man} and Eom, {Bang Wool}",
year = "2016",
month = "5",
day = "31",
doi = "10.1186/s12885-016-2336-8",
language = "English",
volume = "16",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

Park, JY, Kim, YW, Ryu, KW, Nam, BH, Lee, YJ, Jeong, SH, Park, JH, Hur, H, Han, SU, Min, JS, An, JY, Hyung, W, Cho, GS, Jeong, GA, Jeong, O, Park, YK, Jung, MR, Yoon, HM & Eom, BW 2016, 'Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol', BMC cancer, vol. 16, no. 1, 340. https://doi.org/10.1186/s12885-016-2336-8

Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol. / Park, Ji Yeon; Kim, Young Woo; Ryu, Keun Won; Nam, Byung Ho; Lee, Young Joon; Jeong, Sang Ho; Park, Ji Ho; Hur, Hoon; Han, Sang Uk; Min, Jae Seok; An, Ji Yeong; Hyung, WooJin; Cho, Gyu Seok; Jeong, Gui Ae; Jeong, Oh; Park, Young Kyu; Jung, Mi Ran; Yoon, Hong Man; Eom, Bang Wool.

In: BMC cancer, Vol. 16, No. 1, 340, 31.05.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol

AU - Park, Ji Yeon

AU - Kim, Young Woo

AU - Ryu, Keun Won

AU - Nam, Byung Ho

AU - Lee, Young Joon

AU - Jeong, Sang Ho

AU - Park, Ji Ho

AU - Hur, Hoon

AU - Han, Sang Uk

AU - Min, Jae Seok

AU - An, Ji Yeong

AU - Hyung, WooJin

AU - Cho, Gyu Seok

AU - Jeong, Gui Ae

AU - Jeong, Oh

AU - Park, Young Kyu

AU - Jung, Mi Ran

AU - Yoon, Hong Man

AU - Eom, Bang Wool

PY - 2016/5/31

Y1 - 2016/5/31

N2 - Background: Along with the marked increase in early gastric cancer (EGC) in the Eastern countries, there has been an effort to adopt the sentinel node concept in EGC to preserve gastric function and reduce the occurrence of postoperative complications. Based on promising results from a previous quality control study, this prospective multicenter randomized controlled phase III clinical trial aims to elucidate the oncologic safety of laparoscopic stomach-preserving surgery with sentinel basin dissection (SBD) compared to a standard laparoscopic gastrectomy. Methods/Design: This trial is an investigator-initiated, open-label, multicenter randomized controlled phase III trial with a non-inferiority design. Patients diagnosed with a single lesion of clinical stage T1N0M0 gastric adenocarcinoma, with a diameter of 3 cm or less are eligible for the present study. A total of 580 patients (290 per group) will be randomized to either laparoscopic stomach-preserving surgery with SBD or standard surgery. The primary end-point is 3-year disease-free survival (DFS) and the secondary endpoints include postoperative morbidity and mortality, quality of life, 5-year DFS, and overall survival. Qualified investigators who completed the prior quality control study are exclusively allowed to participate in this phase III clinical trial. Discussion: The proposed trial is expected to verify whether laparoscopic stomach-preserving surgery with SBD achieves similar oncologic outcomes and improved quality of life compared to a standard gastrectomy in EGC patients. Trial registration: This study was registered at the NIH ClinicalTrial.gov database ( NCT01804998 ) on March 4th, 2013.

AB - Background: Along with the marked increase in early gastric cancer (EGC) in the Eastern countries, there has been an effort to adopt the sentinel node concept in EGC to preserve gastric function and reduce the occurrence of postoperative complications. Based on promising results from a previous quality control study, this prospective multicenter randomized controlled phase III clinical trial aims to elucidate the oncologic safety of laparoscopic stomach-preserving surgery with sentinel basin dissection (SBD) compared to a standard laparoscopic gastrectomy. Methods/Design: This trial is an investigator-initiated, open-label, multicenter randomized controlled phase III trial with a non-inferiority design. Patients diagnosed with a single lesion of clinical stage T1N0M0 gastric adenocarcinoma, with a diameter of 3 cm or less are eligible for the present study. A total of 580 patients (290 per group) will be randomized to either laparoscopic stomach-preserving surgery with SBD or standard surgery. The primary end-point is 3-year disease-free survival (DFS) and the secondary endpoints include postoperative morbidity and mortality, quality of life, 5-year DFS, and overall survival. Qualified investigators who completed the prior quality control study are exclusively allowed to participate in this phase III clinical trial. Discussion: The proposed trial is expected to verify whether laparoscopic stomach-preserving surgery with SBD achieves similar oncologic outcomes and improved quality of life compared to a standard gastrectomy in EGC patients. Trial registration: This study was registered at the NIH ClinicalTrial.gov database ( NCT01804998 ) on March 4th, 2013.

UR - http://www.scopus.com/inward/record.url?scp=84971577829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971577829&partnerID=8YFLogxK

U2 - 10.1186/s12885-016-2336-8

DO - 10.1186/s12885-016-2336-8

M3 - Article

C2 - 27246120

AN - SCOPUS:84971577829

VL - 16

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 340

ER -